ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1918

Characterising the Specificity, Function and Behavior of CD4+ T Cells Initiating Inflammation in a Murine Model of Rheumatoid Arthritis

Robert Benson1, Catriona Prendergast2, Iain B McInnes2, James Brewer3 and Paul Garside4, 1nstitute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom, 3Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 4University of Glasgow, Glasgow, Great Britain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Dendritic cells, imaging techniques and immune activation, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Poster Session I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: CD4+ T cells are important contributors to the pathogenesis of Rheumatoid Arthritis (RA). The presence of activated T cells in the inflamed synovium, strong associations with HLA-DR4, ptpn22, ctla4 and cd28 implicate their contribution, while the success of T cell targeted CTLA-4-Ig therapeutic provide more direct evidence. Yet it remains unclear when and where CD4+ T cells mediate this pathogenic effect and whether the specificity of the cells is important.

Methods: A variation of antigen-induced arthritis using ovalbumin (OVA) as the inciting challenge was used to model articular inflammation. Th1 polarised OVA specific fluorescent (DsRed) OT-II TcR transgenic T cells were adoptively transferred and expanded in vivo by challenge with OVA/CFA. This allowed subsequent analysis and tracking of antigen-specific T cells as they were recruited to the ankle joint following periarticular injection of heat aggregated OVA (HAO). Flow cytometry allowed phenotyping of cells recruited to the inflamed articular environment. The T cell receptor (TcR) diversity of infiltrating endogenous T cells was assessed by PCR of Vβ genes. Dynamic interactions of responding DsRed T cell populations with joint residing CD11c YFP dendritic cells were visualized using intravital multiphoton laser scanning microscopy.

Results: Low numbers of the inciting OVA specific CD4+ T cells could be found in the joint tissue. However, a large influx of endogenous CD4+ T cells of unknown antigen specificity was also found. In comparison with the CD4+ T cells in the draining lymph node, this recruited T cell population expressed surface activation markers, produced TNFa and IFNg upon ex vivo restimulation and exhibited a narrower range of T cell receptor Vb usage. In addition, intravital imaging of the inflamed joint revealed that a sub-population of this infiltrate demonstrated slower motility speeds and longer periods of contact with articular dendritic cells, while others rapidly migrated throughout the tissue.

Conclusion: We present data demonstrating that while the numbers of inciting antigen-specific T cells to the joint tissue is small, it is associated with a subsequent influx of a large endogenous population of unknown antigen specificity that had acquired the ability to secrete pro-inflammtory cytokines. Oligoclonal TcR Vβ gene expression by the CD4+ T cells in the inflamed joint suggests some degree of antigen-specificity in recruitment while intravital imaging reveals that some of this infiltrate exhibits behaviour consistent with recognition of cognate peptide-MHCII.


Disclosure: R. Benson, None; C. Prendergast, None; I. B. McInnes, BMS, Pfizer, Celgene, Astra Zeneca, 2; J. Brewer, None; P. Garside, None.

To cite this abstract in AMA style:

Benson R, Prendergast C, McInnes IB, Brewer J, Garside P. Characterising the Specificity, Function and Behavior of CD4+ T Cells Initiating Inflammation in a Murine Model of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/characterising-the-specificity-function-and-behavior-of-cd4-t-cells-initiating-inflammation-in-a-murine-model-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterising-the-specificity-function-and-behavior-of-cd4-t-cells-initiating-inflammation-in-a-murine-model-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology